Article info
PDFPostScript
Correspondence
Clinical and laboratory characteristics of acute myeloid leukaemia (AML) at relapse and the risk of acute incapacitation
- Correspondence to Dr Matthew Smith, Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, West Smithfield, London EC1A 7BE, UK; matthew.smith{at}bartshealth.nhs.uk
Citation
Clinical and laboratory characteristics of acute myeloid leukaemia (AML) at relapse and the risk of acute incapacitation
Publication history
- Received August 9, 2015
- Revised September 26, 2015
- Accepted September 30, 2015
- First published October 21, 2015.
Online issue publication
July 05, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/